Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Hydrocodone Bitartrate 20 mg Slow Release Capsules are designed with Methocel E4M, a controlled-release polymer. This formulation allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. It is used to treat conditions such as chronic pain, neuropathic pain, fibromyalgia, arthritis, and migraines. The slow release mechanism ensures long-lasting relief, reduces dosing frequency, and improves patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hydrocodone Bitartrate 20 mg Slow Release Capsules are a specialized compounded formulation designed to provide sustained relief from moderate to severe pain. This formulation is encapsulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient, hydrocodone bitartrate, over an extended period of time. This slow and steady release mechanism offers consistent therapeutic effects, reducing the need for frequent dosing and enhancing patient compliance, particularly for medications that require a controlled and prolonged release profile.
This formulation is primarily used to manage various types of pain, including chronic pain, cancer-related pain, and post-operative pain. However, it is crucial to understand that Hydrocodone Bitartrate 20 mg Slow Release Capsules should not be used for treating pain that is not severe or not expected to last for more than a few days. Misuse of this medication can lead to addiction, overdose, or death, especially in individuals with a history of drug abuse or addiction.
At Bayview Pharmacy, our team of compounding pharmacists is well-versed in the intricacies of this formulation. We are committed to providing comprehensive guidance to both patients and prescribers regarding the appropriate use of Hydrocodone Bitartrate 20 mg Slow Release Capsules. If you have any queries or concerns about this medication, we encourage you to reach out to us for further assistance.
Hydrocodone Bitartrate 20 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer, designed to gradually release the encapsulated medication over an extended period of time. This formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
It's important to note that this formulation may interact with other medications, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Patients should inform their healthcare provider of all medications they are taking, including any herbal supplements, before starting treatment with this formulation.
Patients should be aware that this formulation may cause drowsiness and should not drive or operate machinery until they know how this medication affects them. Alcohol should be avoided while taking this medication.
This formulation may cause constipation. To help prevent this side effect, patients should drink plenty of fluids and eat a high-fiber diet.
Dizziness is another potential side effect. Patients should not stand up quickly after sitting or lying down to avoid this.
This formulation may cause dry mouth. Drinking plenty of fluids can help prevent this side effect.
Nausea may occur with this medication. Taking it with food can help prevent this side effect.
This formulation may cause increased sweating. Wearing loose-fitting clothing can help manage this side effect.
Blurred vision may occur with this medication. Patients should not drive or operate machinery until they know how this medication affects them.
This formulation may cause difficulty urinating. Drinking plenty of fluids can help prevent this side effect.
Respiratory depression is a serious potential side effect of this formulation. Patients with any respiratory problems should not take this medication.
This formulation may increase the risk of seizures. Patients with a history of seizures should not take this medication.
There is an increased risk of addiction with this formulation. Patients with a history of substance abuse should not take this medication.
If you have any questions about the interactions of this formulation, please reach out to your healthcare provider.
Hydrocodone Bitartrate 20 mg Slow Release Capsules are a potent opioid analgesic medication, primarily used for the management of moderate to severe pain. This particular formulation is designed with Methocel E4M, a type of controlled-release polymer. This technology allows for a gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects and more consistent pain relief. This slow release formulation reduces the frequency of dosing and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
The slow release of the medication ensures a prolonged relief from coughing, enhancing patient comfort.
It is crucial to take this medication as directed by your healthcare provider. The capsule should be swallowed whole with a full glass of water, ideally at the same time each day to maintain a consistent level of the medication in your system. It is important not to crush, chew, or break the capsule as this can lead to a rapid release of the medication, potentially causing adverse effects.
Hydrocodone Bitartrate can be habit-forming, and it is essential to only take it as prescribed. Do not exceed the prescribed dose or frequency of administration. If you experience any side effects such as nausea, vomiting, dizziness, or drowsiness, it is important to contact your healthcare provider immediately.
If you have any questions or concerns about Hydrocodone Bitartrate 20 mg Slow Release Capsules, please do not hesitate to reach out to us. We are committed to helping you understand your medication and get the most out of your treatment.
Hydrocodone Bitartrate 20 mg Slow Release Capsules are a compounded formulation designed to provide sustained therapeutic effects over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer that gradually releases the encapsulated medication. This slow-release mechanism reduces the frequency of dosing and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules may be used to treat a variety of conditions, including severe cough, diarrhea, and dyspnea. They can also serve as an adjunct to other medications for the management of moderate to severe pain. However, it is crucial to understand that this formulation should not be used continuously for more than a few days, as prolonged use can lead to physical dependence and addiction.
Patients should also be aware of potential side effects, which may include drowsiness, dizziness, and confusion. As such, it is advised not to use this medication while operating heavy machinery or driving. Furthermore, this formulation should not be taken in conjunction with alcohol or other drugs that can cause drowsiness, as this can exacerbate these side effects.
It is always important to use this medication responsibly and under the guidance of a healthcare professional. If you have any questions or concerns about the use of Hydrocodone Bitartrate 20 mg Slow Release Capsules, it is recommended to consult with your healthcare provider.
Hydrocodone Bitartrate 20 mg Slow Release Capsules is a medication that is formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time, offering sustained therapeutic effects.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Due to the controlled-release polymer in the formulation, the frequency of dosing is reduced. However, the exact frequency will depend on your doctor's prescription. Always follow the instructions provided by your healthcare provider.
Slow-release medications offer several benefits. They provide sustained therapeutic effects over an extended period of time, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
No, you should not break or crush the capsules. Doing so can interfere with the controlled-release mechanism and may lead to the rapid release of the medication, which can be dangerous.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Like all medications, Hydrocodone Bitartrate 20 mg Slow Release Capsules can have side effects. These can include dizziness, lightheadedness, nausea, vomiting, and constipation. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
No, you should avoid alcohol while taking this medication. Alcohol can increase the risk of serious side effects, including slowed or difficulty breathing and death.
Hydrocodone Bitartrate 20 mg Slow Release Capsules should only be used during pregnancy or while breastfeeding if the potential benefits outweigh the potential risks. Always consult your healthcare provider before taking any medication while pregnant or breastfeeding.
If you suspect an overdose, seek emergency medical attention immediately. Symptoms of an overdose can include slow breathing, severe drowsiness, muscle weakness, cold and clammy skin, pinpoint pupils, and fainting.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
